APL
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301) (NCT07296445) | SDK Therapeutics, Inc. | 2026-01-01 |
| Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL). (NCT07503730) | First Affiliated Hospital Xi'an Jiaotong University | 2025-06-01 |
| Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia (NCT05881265) | Shanghai Jiao Tong University School of Medicine | 2023-05-15 |
| Clinical Guidelines for APL Treatment (NCT02020161) | PETHEMA Foundation | 2012-06-01 |
Track APL automatically
Every clearance here is in the API, with alerts when new ones post.